Management of Priapism

Introduction to Priapism

The American Urological Association recommends that priapism be treated as a urologic emergency, with immediate evaluation to differentiate ischemic from non-ischemic subtypes, as management differs completely and delayed treatment of ischemic priapism results in permanent erectile dysfunction in 90% of cases after 48 hours 1, 2

The European Association of Urology suggests obtaining cavernosal blood gas analysis immediately to classify priapism as ischemic (pO2 <30 mmHg, pCO2 >60 mmHg, pH <7.25) or non-ischemic (normal arterial blood gas values) 1, 2, 3
If blood gas is unavailable, use color Doppler ultrasound showing minimal to absent cavernosal arterial flow for ischemic type versus high arterial flow for non-ischemic type 2, 3

The American Urological Association recommends beginning immediate corporal aspiration with intracavernosal phenylephrine injection to achieve detumescence in 43-81% of cases 1, 2, 3
Aspirate 20-30 mL of blood from corpora cavernosa using 16-19 gauge butterfly needle and inject phenylephrine 100-500 mcg/mL concentration, with a maximum dose of 1000 mcg within the first hour 2
Repeat injections every 3-5 minutes as needed before considering surgical intervention 2
Intervention must begin within 4-6 hours to preserve erectile function, with risk of permanent erectile dysfunction increasing dramatically after 24 hours and approaching 90% after 48 hours 1, 3

The European Association of Urology suggests initial management with observation and conservative measures, as many cases resolve spontaneously without intervention 5, 6, 7
If patient requests treatment or priapism persists, perform selective arterial embolization using temporary absorbable materials, with a 74% resolution rate and only 5% erectile dysfunction rate 5, 6, 7

The American Urological Association recommends implementing preventive pharmacotherapy to reduce future episodes, including PDE5 inhibitors and hormonal therapy options based on underlying etiology 2, 3
Educate patients on home self-administration of intracavernosal phenylephrine for episodes approaching but not yet meeting the 4-hour threshold 2

The National Institute of Diabetes and Digestive and Kidney Diseases recommends immediate urologic intracavernosal treatment identical to other ischemic priapism cases, without delay for systemic sickle cell interventions alone 1, 2, 3
Provide concurrent systemic sickle cell management alongside urologic intervention, not as a substitute 3

Never delay ischemic priapism treatment waiting for spontaneous resolution or attempting conservative measures alone, as every hour of delay increases permanent erectile dysfunction risk 1
Never treat non-ischemic priapism as an emergency with aspiration and sympathomimetics, as this provides no benefit and risks complications 6, 7
Never use permanent embolization materials as first-line for non-ischemic priapism, due to the 7-fold higher erectile dysfunction rate (39% vs 5%) 5, 6
Never exceed 1000 mcg phenylephrine in the first hour due to systemic cardiovascular effects (hypertension, reflex bradycardia) 2, 3